Search results
This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?
Motley Fool via Yahoo Finance· 2 hours agoIf it fails this study, it could be pulled off the market. Still, INO-3107 could hit the market by...
Inovio Pharmaceuticals: Neutral On INO-3107 Amidst Stock Dilution And High Valuation
Seeking Alpha· 2 weeks agoAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the...
INOVIO Reports Inducement Grants Under Inducement Plan
Morningstar· 4 days agoINOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and ...
Japan’s Next Emerging Designer Wave
The Business of Fashion· 5 days agoEmotions were running high at last month’s Viviano show in Tokyo. Designer Viviano Sue sent models down the runway in dark yet romantic looks replete...